StockWatch
·

Aspira Pathlab & Diagnostics Ltd Q3 FY26 Results

ASPIRAQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue5.1236.8%5.3%
Total Income5.2536.3%4.5%
Expenditure6.816.5%33.0%
PBT-1.56185.1%514.1%
Net Profit-1.56185.1%514.1%
OPM-23.64%50.69pp20.09pp
NPM-29.75%52.05pp36.61pp
EPS1.5214.6%310.8%
View full financials

Informational and educational content only. Not investment advice.